Epirubicin
Hydrochloride Injection
| General Information: Epirubicin hydrochloride
injection is typically utilized in the treatment of axillary node tumor involvement in breast cancer. For indication, dosing and other information, please refer to the manufacture package insert. |
| |
| Manufacturer |
Products |
Size |
NDC |
PI |
MSDS |
| Sagent |
Epirubicin |
50mg/25mL |
25021-0203-25 |
PI |
MSDS |
| |
|
200mg/100mL |
25201-0203-51 |
PI |
MSDS |
|
| |
| Clinical
Data: For any questions
or for further information
related to Epirubicin hydrochloride
injection, clinical
pharmacology, additional
indications and usages,
contraindications, warnings,
precautions, adverse reactions,
dosage, administration and/or
storage of this product, please
contact
BDI Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |